Silverback Therapeutics, Inc. - Common Stock (NQ:SBTX)

ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis

February 22, 2023

ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023

February 09, 2023

ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis

November 10, 2022

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

November 08, 2022

Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis

October 21, 2022

SILVERBACK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Silverback Therapeutics, Inc. - SBTX

October 14, 2022

From Kahn Swick & Foti, LLC

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silverback Therapeutics, Inc. (Nasdaq - SBTX), One Medical (Nasdaq - ONEM), Hanger, Inc. (NYSE - HNGR), VMware, Inc. (NYSE - VMW)

July 26, 2022

From Brodsky & Smith LLC

SILVERBACK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Silverback Therapeutics, Inc. - SBTX

July 22, 2022

From Kahn Swick & Foti, LLC

SBTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Silverback Therapeutics, Inc. Is Fair to Shareholders

July 21, 2022

From Halper Sadeh LLP

Silverback Therapeutics and ARS Pharmaceuticals Announce Merger

July 21, 2022

Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

May 17, 2022

Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

May 12, 2022

Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results

March 31, 2022

NASDAQ:SBTX Investor Notice: Investigation over Possible Securities Laws Violations by Silverback Therapeutics, Inc. ↗

March 04, 2022

San Diego, CA -- (SBWIRE) -- 03/04/2022 -- Silverback Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Silverback Therapeutics to Present at the 42nd Annual Cowen Healthcare Conference

February 24, 2022

Silverback Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

February 03, 2022

Silverback Therapeutics to Participate in the H.C. Wainwright Bioconnect Conference

January 05, 2022

From Silverback Therapeutics

Final Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

January 04, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

SBTX Final Deadline - Bronstein, Gewirtz & Grossman, LLC Reminds Silverback Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 4, 2022

Topics Lawsuit

January 04, 2022

From Bronstein, Gewirtz & Grossman, LLC

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Silverback Deadline Alert

January 03, 2022

Deadline Tomorrow Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

January 03, 2022

Los Angeles - (NewMediaWire) - January 03, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Silverback Therapeutics,...

SILVERBACK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Silverback Therapeutics, Inc. and Encourages Investors to Contact the Firm

Topics Lawsuit

January 02, 2022

From Bragar Eagel & Squire, P.C.

Deadline Tuesday Notice: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

December 31, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Topics Lawsuit

Silverback Shareholder Notice

December 31, 2021

Deadline Tuesday Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

December 30, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Topics Lawsuit

Silverback Shareholder Notice

December 29, 2021

Tuesday Deadline Reminder: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

December 29, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Topics Lawsuit

Silverback Shareholder Alert

December 28, 2021

7-Day Deadline Reminder: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

December 28, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.